New Study & Pfizer Docs. Describe Potential C0V|D “V@XX Shedding”
May 10, 2022 | BY |
New Study & Confidential Pfizer Docs. prove COVID “Vaccine Shedding” has been and still is occurring with dangerous consequences
“A new study conducted by scientists at the University of Colorado confirms the vast majority of humanity have had absolutely no choice in the matter of whether they wish to get the Covid-19 injection or not because the vaccinated have been transmitting antibodies generated by the injections through aerosols.
The findings should however come as no surprise, because a confidential Pfizer document had already confirmed exposure to the mRNA injections was perfectly possible by skin-to-skin contact and breathing the same air as someone who had been given the Covid-19 jab.
They also unfortunately add weight to the claims made by Dr Phillipe van Welbergen, who demonstrated that graphene, an alleged undisclosed ingredient of the Covid-19 injections, is being transmitted from the vaccinated to the not-vaccinated and destroying red blood cells and causing dangerous blood clots.
The latest study, titled ‘Evidence for Aerosol Transfer of SARS-CoV2-specific Humoral Immunity’, and published 1st May 2022, was conducted by the following scientists for the University of Colorado –
- Ross M. Kedl, Elena Hsieh,
- Thomas E. Morrison,
- Gabriela Samayoa-Reyes,
- Siobhan Flaherty,
- Conner L. Jackson,
- Rosemary Rochford.
The abstract of the study reads as follows –
Despite the obvious knowledge that infectious particles can be shared through respiration, whether other constituents of the nasal/oral fluids can be passed between hosts has surprisingly never even been postulated, let alone investigated.
The circumstances of the present pandemic facilitated a unique opportunity to fully examine this provocative idea. The data we show provides evidence for a new mechanism by which herd immunity may be manifested, the aerosol transfer of antibodies between immune and non-immune hosts.
And here are the study authors main findings –
The extended mandates for mask wearing in both social and work environments provided a unique opportunity to evaluate the possibility of aerosolized antibody expiration from vaccinated individuals.
Utilizing a flow cytometry-based Multiplex Microsphere Immunoassay (MMIA) to detect SARS-CoV-2-specific antibodies (Fig 1A and B) 4,5 and a method previously used to elute antibody from rehydrated dried blood spots (DBS), we identified anti-SARS-CoV-2 specific antibodies eluted from surgical face masks worn by vaccinated lab members donated at the end of one workday.
Consistent with the results reported by others, we identified both IgG and IgA in saliva from vaccinated individuals (Fig 1C and D). It was therefore not surprising to detect both IgG and IgA following elution of antibody from face masks (Fig 1Cand D).
Given these observations, we hypothesized that droplet/aerosolized antibody transfer might occur between individuals, much like droplet/aerosolized virus particles can be exchanged by the same route.
This means Covid-19 vaccine shedding is perfectly possible when we take into account a study performed on behalf of Pfizer in Japan.
The study observed the distribution of the Covid-19 injection in the bodies of Wister Rats over a period of 48 hours. One of the most concerning findings from the study is the fact that the Pfizer injection accumulates in the ovaries over time. The highest concentration was noted in the liver. But it also accumulates in the salivary glands on the skin.
It is not known if the injection continues to accumulate after 48 hours due to observations being stopped after this amount of time in the study. But these results coupled with the first study above tell us that for a minimum of 48 hours, an unvaccinated person is at risk of being exposed to the Covid-19 injection if they breathe the same air as or touch the skin of a person who has been vaccinated.
This should however come as no surprise because Pfizer admitted as much in their ‘A PHASE 1/2/3, PLACEBO-CONTROLLED, RANDOMIZED, OBSERVER-BLIND, DOSE-FINDING STUDY TO EVALUATE THE SAFETY, TOLERABILITY, IMMUNOGENICITY, AND EFFICACY OF SARS-COV-2 RNA VACCINE CANDIDATES AGAINST COVID-19 IN HEALTHY INDIVIDUALS’ document.
The document contains a whole section covering the possibility of ‘mRNA vaccine shedding’ in which it is possible for those who have been in close proximity of someone who has had the Pfizer mRNA jab to suffer an adverse reaction.”
Compilation of Information on Graphene Oxide | For Life On Earth | Source
Chinese Patent CN112220919A CV Vaxx contains graphene oxide
“A coronavirus vaccine, wherein said coronavirus comprises graphene oxide” Link To Patent
中华人民共和国国家知识产权局
以氧化石墨烯为载体的纳米冠状病毒重组 疫苗
摘要
本发明属于纳米材料和生物医药领域，涉及 一种疫苗，具体而言，涉及2019‐nCoV冠状病毒核 重组纳米疫苗的开发。本发明还包括该疫苗的制 备方法以及在动物试验中的应用。所述的新冠疫 苗含有氧化石墨烯、肌肽、CpG、新冠病毒RBD;在 氧化石墨烯的骨架上结合肌肽、CpG和新冠病毒 RBD;所述的CpG的编码序列如SEQ ID NO 1所示; 所述的新冠病毒RBD是指新型冠状病毒蛋白受体 结合区域可以在小鼠体内产生高效价的针对RBD 的特异性抗体，为新型冠状病毒的防治提供了强 有力的支持。
Link To_Graphene oxide carrier-based recombinant vaccine for coronavirus nanoparticles_CN112220919A
“The novel coronavirus vaccine contains graphene oxide” LINK
“The novel coronavirus vaccine contains graphene oxide” LINK
“Graphene oxide (GO) has become a topic of increasing concern for its environmental and health risks.”
31 May 2012
Chen, L., Hu, P., Zhang, L. et al. Toxicity of graphene oxide and multi-walled carbon nanotubes against human cells and zebrafish. Sci. China Chem. 55, 2209–2216 (2012). https://doi.org/10.1007/s11426-012-4620-z
“Collectively, our work suggests that GO does actual toxicity to organisms posing potential environmental risks and the result is also shedding light on the geometrical structure-dependent toxicity of graphitic nanomaterials.” LINK
Toxicity of graphene-family nanoparticles: a general review of the origins and mechanisms
https://www.sciencedirect.com/science/article/pii/S0160412019300704#s0085
Toxicology of graphene based materials
December 2020
“Potential of graphene-based materials to combat COVID-19: properties, perspectives, and prospects” Link
Link To Article_October 2020_Potential of graphene-based materials to combat COVID-19: properties, perspectives, and prospects
“…To date, there is no medicine and vaccine available for COVID-19 treatment. While the development of medicines and vaccines are essentially and urgently required, what is also extremely important is the repurposing of smart materials to design effective systems for combating COVID-19. Graphene and graphene-related materials (GRMs) exhibit extraordinary physicochemical, electrical, optical, antiviral, antimicrobial, and other fascinating properties that warrant them as potential candidates for designing and development of high-performance components and devices required for COVID-19 pandemic and other futuristic calamities. In this article, we discuss the potential of graphene and GRMs for healthcare applications and how they may contribute to fighting against COVID-19.”